Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-12-2012 | Research

The prognostic value of schizontaemia in imported Plasmodium falciparum malaria

Authors: Marlies E van Wolfswinkel, Mariana de Mendonça Melo, Klaske Vliegenthart-Jongbloed, Rob Koelewijn, Jaap J van Hellemond, Perry J van Genderen

Published in: Malaria Journal | Issue 1/2012

Login to get access

Abstract

Background

In Plasmodium falciparum infection, peripheral parasite counts do not always correlate well with the sequestered parasite burden. As erythrocytes parasitized with mature trophozoites and schizonts have a high tendency to adhere to the microvascular endothelium, they are often absent in peripheral blood samples. The appearance of schizonts in peripheral blood smears is thought to be a marker of high sequestered parasite burden and severe disease. In the present study, the value of schizontaemia as an early marker for severe disease in non-immune individuals with imported malaria was evaluated.

Methods

All patients in the Rotterdam Malaria Cohort diagnosed with P. falciparum malaria between 1 January 1999 and 1 January 2012 were included. Thick and thin blood films were examined for the presence of schizontaemia. The occurrence of WHO defined severe malaria was the primary endpoint. The diagnostic performance of schizontaemia was compared with previously evaluated biomarkers C-reactive protein and lactate.

Results

Schizonts were present on admission in 49 of 401 (12.2%) patients. Patients with schizontaemia were more likely to present with severe malaria, a more complicated course and had longer duration of admission in hospital. Schizontaemia had a specificity of 0.95, a sensitivity of 0.53, a negative predictive value of 0.92 and a positive predictive value of 0.67 for severe malaria. The presence of schizonts was an independent predictor for severe malaria.

Conclusion

Absence of schizonts was found to be a specific marker for exclusion of severe malaria. Presence of schizonts on admission was associated with a high positive predictive value for severe malaria. This may be of help to identify patients who are at risk of a more severe course than would be expected when considering peripheral parasitaemia alone.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mackintosh CL, Beeson JG, Marsh K: Clinical features and pathogenesis of severe malaria. Trends Parasitol. 2004, 20: 597-603. 10.1016/j.pt.2004.09.006.CrossRefPubMed Mackintosh CL, Beeson JG, Marsh K: Clinical features and pathogenesis of severe malaria. Trends Parasitol. 2004, 20: 597-603. 10.1016/j.pt.2004.09.006.CrossRefPubMed
3.
go back to reference Miller LH, Baruch DI, Marsh K, Doumbo OK: The pathogenic basis of malaria. Nature. 2002, 415: 673-679. 10.1038/415673a.CrossRefPubMed Miller LH, Baruch DI, Marsh K, Doumbo OK: The pathogenic basis of malaria. Nature. 2002, 415: 673-679. 10.1038/415673a.CrossRefPubMed
4.
go back to reference Franke-Fayard B, Fonager J, Braks A, Khan SM, Janse CJ: Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria?. PLoS Pathog. 2010, 6: e1001032-10.1371/journal.ppat.1001032.PubMedCentralCrossRefPubMed Franke-Fayard B, Fonager J, Braks A, Khan SM, Janse CJ: Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria?. PLoS Pathog. 2010, 6: e1001032-10.1371/journal.ppat.1001032.PubMedCentralCrossRefPubMed
5.
go back to reference Field JW: Blood examination and prognosis in acute falciparum malaria. Trans R Soc Trop Med Hyg. 1949, 43: 33-48. 10.1016/0035-9203(49)90022-X.CrossRefPubMed Field JW: Blood examination and prognosis in acute falciparum malaria. Trans R Soc Trop Med Hyg. 1949, 43: 33-48. 10.1016/0035-9203(49)90022-X.CrossRefPubMed
6.
go back to reference Silamut K, White NJ: Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg. 1993, 87: 436-443. 10.1016/0035-9203(93)90028-O.CrossRefPubMed Silamut K, White NJ: Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg. 1993, 87: 436-443. 10.1016/0035-9203(93)90028-O.CrossRefPubMed
7.
go back to reference Lwin KM, Ashley EA, Proux S, Silamut K, Nosten F, McGready R: Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report. Malar J. 2008, 7: 57-10.1186/1475-2875-7-57.PubMedCentralCrossRefPubMed Lwin KM, Ashley EA, Proux S, Silamut K, Nosten F, McGready R: Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report. Malar J. 2008, 7: 57-10.1186/1475-2875-7-57.PubMedCentralCrossRefPubMed
8.
go back to reference Young MD: The prognostic value of finding schizonts of Plasmodium falciparum in the peripheral blood. Trans R Soc Trop Med Hyg. 1995, 89: 237-CrossRefPubMed Young MD: The prognostic value of finding schizonts of Plasmodium falciparum in the peripheral blood. Trans R Soc Trop Med Hyg. 1995, 89: 237-CrossRefPubMed
10.
go back to reference World Health Organization: Communicable Diseases Cluster: Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000, 94 (Suppl 1): S1-S90.CrossRef World Health Organization: Communicable Diseases Cluster: Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000, 94 (Suppl 1): S1-S90.CrossRef
11.
go back to reference van Gool T, van Wolfswinkel ME, Koelewijn R, van Thiel PP, Jacobs J, van Hellemond JJ, van Genderen PJ: A simple and fast method to exclude high Plasmodium falciparum parasitaemia in travellers with imported malaria. Malar J. 2011, 10: 300-10.1186/1475-2875-10-300.PubMedCentralCrossRefPubMed van Gool T, van Wolfswinkel ME, Koelewijn R, van Thiel PP, Jacobs J, van Hellemond JJ, van Genderen PJ: A simple and fast method to exclude high Plasmodium falciparum parasitaemia in travellers with imported malaria. Malar J. 2011, 10: 300-10.1186/1475-2875-10-300.PubMedCentralCrossRefPubMed
12.
go back to reference van Genderen PJ, Hesselink DA, Bezemer JM, Wismans PJ, Overbosch D: Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol. Transfusion. 2010, 50: 787-794. 10.1111/j.1537-2995.2009.02488.x.CrossRefPubMed van Genderen PJ, Hesselink DA, Bezemer JM, Wismans PJ, Overbosch D: Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol. Transfusion. 2010, 50: 787-794. 10.1111/j.1537-2995.2009.02488.x.CrossRefPubMed
13.
go back to reference van Wolfswinkel ME, Hesselink DA, Zietse R, Hoorn EJ, van Genderen PJ: Hyponatraemia in imported malaria is common and associated with disease severity. Malar J. 2010, 25: 140-CrossRef van Wolfswinkel ME, Hesselink DA, Zietse R, Hoorn EJ, van Genderen PJ: Hyponatraemia in imported malaria is common and associated with disease severity. Malar J. 2010, 25: 140-CrossRef
14.
go back to reference Van Genderen PJ, van der Meer IM, Consten J, Petit PLC, van Gool T, Overbosch D: Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria. J Travel Med. 2005, 12: 261-264.CrossRefPubMed Van Genderen PJ, van der Meer IM, Consten J, Petit PLC, van Gool T, Overbosch D: Evaluation of plasma lactate as a parameter for disease severity on admission in travelers with Plasmodium falciparum malaria. J Travel Med. 2005, 12: 261-264.CrossRefPubMed
15.
go back to reference van Wolfswinkel ME, Hesselink DA, Hoorn EJ, de Rijke YB, Koelewijn R, van Hellemond JJ, van Genderen PJ: Copeptin does not accurately predict disease severity in imported malaria. Malar J. 2012, 5: 11-16. van Wolfswinkel ME, Hesselink DA, Hoorn EJ, de Rijke YB, Koelewijn R, van Hellemond JJ, van Genderen PJ: Copeptin does not accurately predict disease severity in imported malaria. Malar J. 2012, 5: 11-16.
16.
go back to reference Lew VL: Malaria: endless fascination with merozoite release. Curr Biol. 2005, 15: R760-R761. 10.1016/j.cub.2005.08.059.CrossRefPubMed Lew VL: Malaria: endless fascination with merozoite release. Curr Biol. 2005, 15: R760-R761. 10.1016/j.cub.2005.08.059.CrossRefPubMed
17.
go back to reference Dondorp A, Nosten F, Stepniewska K, Day N, White N: South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group: Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005, 366: 717-725.CrossRefPubMed Dondorp A, Nosten F, Stepniewska K, Day N, White N: South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group: Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005, 366: 717-725.CrossRefPubMed
18.
go back to reference Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ, AQUAMAT group: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010, 376: 1647-1657. 10.1016/S0140-6736(10)61924-1.PubMedCentralCrossRefPubMed Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ, AQUAMAT group: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010, 376: 1647-1657. 10.1016/S0140-6736(10)61924-1.PubMedCentralCrossRefPubMed
19.
go back to reference Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Mørch K, Foroutan B, Suttorp N, Yürek S, Flick H: Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis. 2011, 17: 771-777. 10.3201/eid1705.101229.PubMedCentralCrossRefPubMed Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Mørch K, Foroutan B, Suttorp N, Yürek S, Flick H: Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis. 2011, 17: 771-777. 10.3201/eid1705.101229.PubMedCentralCrossRefPubMed
20.
go back to reference Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WF, Clerinx J, van Veldhuizen CK, de Vries PJ: Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J. 2012, 11: 102-10.1186/1475-2875-11-102.PubMedCentralCrossRefPubMed Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WF, Clerinx J, van Veldhuizen CK, de Vries PJ: Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J. 2012, 11: 102-10.1186/1475-2875-11-102.PubMedCentralCrossRefPubMed
Metadata
Title
The prognostic value of schizontaemia in imported Plasmodium falciparum malaria
Authors
Marlies E van Wolfswinkel
Mariana de Mendonça Melo
Klaske Vliegenthart-Jongbloed
Rob Koelewijn
Jaap J van Hellemond
Perry J van Genderen
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-301

Other articles of this Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.